BR112015005758A2 - métodos para modular níveis de corticosterona em indivíduos psicologicamente estressados - Google Patents

métodos para modular níveis de corticosterona em indivíduos psicologicamente estressados

Info

Publication number
BR112015005758A2
BR112015005758A2 BR112015005758A BR112015005758A BR112015005758A2 BR 112015005758 A2 BR112015005758 A2 BR 112015005758A2 BR 112015005758 A BR112015005758 A BR 112015005758A BR 112015005758 A BR112015005758 A BR 112015005758A BR 112015005758 A2 BR112015005758 A2 BR 112015005758A2
Authority
BR
Brazil
Prior art keywords
methods
corticosterone levels
modulate
modulating
stressed individuals
Prior art date
Application number
BR112015005758A
Other languages
English (en)
Inventor
Vazquez Hernandez Enrique
Ramirez Gonzalez Maria
Buck Rachael
Rueda Cabrera Ricardo
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46940436&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112015005758(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of BR112015005758A2 publication Critical patent/BR112015005758A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Pediatric Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)

Abstract

resumo "métodos para modular níveis de corticosterona em indivíduos psicologicamente estressados" trata-se de métodos para modular e/ou diminuir níveis de corticosterona sé-rica em um indivíduo afetado pelo estresse. adicionalmente, são revelados métodos para modular a resposta de hipotalâmico pituitário adrenal em um indivíduo. os mé-todos incluem a administração de 2-fucosil-lactose a um indivíduo.
BR112015005758A 2012-09-14 2013-09-12 métodos para modular níveis de corticosterona em indivíduos psicologicamente estressados BR112015005758A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12382354.4A EP2708145B1 (en) 2012-09-14 2012-09-14 Nutritional compositions for use in methods for modulating corticosterone levels in psychologically stressed individuals
PCT/US2013/059436 WO2014043330A1 (en) 2012-09-14 2013-09-12 Methods for modulating corticosterone levels in psychologically stressed individuals

Publications (1)

Publication Number Publication Date
BR112015005758A2 true BR112015005758A2 (pt) 2017-07-04

Family

ID=46940436

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015005758A BR112015005758A2 (pt) 2012-09-14 2013-09-12 métodos para modular níveis de corticosterona em indivíduos psicologicamente estressados

Country Status (14)

Country Link
US (3) US10398716B2 (pt)
EP (1) EP2708145B1 (pt)
CN (1) CN104780781B (pt)
BR (1) BR112015005758A2 (pt)
CA (1) CA2884487C (pt)
DK (1) DK2708145T3 (pt)
ES (1) ES2572831T3 (pt)
HK (1) HK1195856A1 (pt)
IL (1) IL237589A0 (pt)
MX (1) MX369453B (pt)
MY (1) MY182944A (pt)
PH (1) PH12015500545A1 (pt)
SG (1) SG11201501976SA (pt)
WO (1) WO2014043330A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2708145B1 (en) 2012-09-14 2016-05-04 Abbott Laboratories Nutritional compositions for use in methods for modulating corticosterone levels in psychologically stressed individuals
ES2795665T3 (es) 2012-09-14 2020-11-24 Abbott Lab Procedimientos para aumentar la funcionalidad cerebral utilizando 2-fucosil-lactosa
TW201438719A (zh) * 2012-12-18 2014-10-16 Abbott Lab 改善壓力症狀之母乳寡糖
US10624916B2 (en) * 2012-12-20 2020-04-21 Abbott Laboratories Nutritional formulations using human milk oligosaccharides for modulating inflammation
US10835544B2 (en) 2014-12-08 2020-11-17 Glycom A/S Synthetic composition for regulating satiety
EP3229812A4 (en) 2014-12-08 2018-10-03 Glycom A/S Synthetic composition for treating metabolic disorders
US20160287637A1 (en) * 2014-12-08 2016-10-06 Glycom A/S Synthetic composition and method for modulating emotion and mood disorders
US10881674B2 (en) 2014-12-08 2021-01-05 Glycom A/S Synthetic composition for treating metabolic disorders
US10987368B2 (en) 2014-12-08 2021-04-27 Glycom A/S Synthetic composition for preventing or treating CVD
CN108348535B (zh) 2015-10-28 2021-08-31 格礼卡姆股份公司 用于调节脑功能和行为的合成组合物和方法
EP3368047B1 (en) * 2015-10-28 2023-04-26 Glycom A/S Synthetic composition and method for modulating emotion and mood disorders
WO2017215722A1 (en) * 2016-06-15 2017-12-21 Glycom A/S Synthetic composition comprising hmo and method for modulating emotion and mood disorders
WO2018157900A1 (en) * 2017-03-01 2018-09-07 Glycom A/S Synthetic composition for microbiota modulation
US20180333426A1 (en) * 2017-05-17 2018-11-22 Mead Johnson Nutrition Company Nutritional composition with human milk oligosaccharides and uses thereof
EP3809878A1 (en) * 2018-06-25 2021-04-28 Société des Produits Nestlé S.A. Composition comprising human milk oligosaccharides for use in improving, enhancing, promoting or modulating a serotonergic function in the central nervous system
WO2024052406A1 (en) * 2022-09-06 2024-03-14 Inbiose N.V. Baked nutritional compositions comprising human milk oligosaccharides

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2184687A1 (en) * 1994-03-09 1995-09-14 Pedro Antonio Prieto Humanized milk
US5891689A (en) 1994-04-12 1999-04-06 Innovir Laboratories, Inc. Heme-bearing microparticles for targeted delivery of drugs
JPH10508579A (ja) 1994-09-20 1998-08-25 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア シナプス伝達を改善する薬
PL343902A1 (en) 1997-02-21 2001-09-10 Abbott Lab Methods of and compositions for reducing enteritis and colitis morbidity rate
US6365218B1 (en) 2000-02-04 2002-04-02 Abbott Laboratories Pediatric formula and methods for providing nutrition and improving tolerance
US6811801B2 (en) 2001-12-12 2004-11-02 Abbott Laboratories Methods and compositions for brightening the color of thermally processed nutritionals
WO2009019032A2 (en) 2003-08-08 2009-02-12 Dsm Ip Assets B.V. Novel method for screening brain-active compounds
WO2008011538A2 (en) 2006-07-19 2008-01-24 The Salk Institute For Biological Studies Methods of using flavonoids to enhance memory
EP2072052A1 (en) * 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
WO2010060722A1 (en) * 2008-11-03 2010-06-03 Nestec S.A. A nutritional composition comprising probiotics and improving sleep patterns
US9012625B2 (en) 2009-04-07 2015-04-21 Glycom A/S Method for the synthesis of a trisaccharide
DK2451462T3 (en) * 2009-07-06 2017-12-11 Children's Hospital Medical Center Inhibition of inflammation with milk oligosaccharides
US20120177691A1 (en) 2009-07-15 2012-07-12 N.V. Nutricia Fucosyllactose as breast milk identical non-digestible oligosaccharide with new functional benefit
CA2822219C (en) 2010-12-31 2020-12-29 Abbott Laboratories Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
MX356184B (es) 2010-12-31 2018-05-17 Abbott Lab Fórmulación pediátrica sintética que comprende un probiótico.
CA3038073C (en) 2010-12-31 2021-05-25 Abbott Laboratories Human milk oligosaccharides for modulating inflammation
ES2804258T3 (es) * 2010-12-31 2021-02-05 Abbott Lab Procedimientos para reducir la incidencia de estrés oxidativo usando oligosacáridos de leche humana, vitamina C y agentes antiinflamatorios
US8703737B2 (en) * 2010-12-31 2014-04-22 Abbott Laboratories Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
CA2822500C (en) 2010-12-31 2022-07-26 Abbott Laboratories Human milk oligosaccharides to promote growth of beneficial bacteria
ES2527200T5 (es) 2011-02-10 2022-12-29 Nestle Sa Modulación del crecimiento de las bífidobacterias mediante una combinación de oligosacáridos de la leche humana
MX350435B (es) 2011-10-18 2017-09-06 Nestec Sa Composicion para uso en el crecimiento del cerebro y/o desarrollo cognitivo y/o desarrollo psicomotor.
EP2708145B1 (en) 2012-09-14 2016-05-04 Abbott Laboratories Nutritional compositions for use in methods for modulating corticosterone levels in psychologically stressed individuals
ES2795665T3 (es) 2012-09-14 2020-11-24 Abbott Lab Procedimientos para aumentar la funcionalidad cerebral utilizando 2-fucosil-lactosa

Also Published As

Publication number Publication date
EP2708145B1 (en) 2016-05-04
WO2014043330A1 (en) 2014-03-20
ES2572831T3 (es) 2016-06-02
DK2708145T3 (en) 2016-07-18
MX2015003368A (es) 2015-10-22
CN104780781B (zh) 2017-03-01
IL237589A0 (en) 2015-04-30
US10398716B2 (en) 2019-09-03
CA2884487C (en) 2017-08-29
CA2884487A1 (en) 2014-03-20
HK1195856A1 (zh) 2014-11-28
MX369453B (es) 2019-11-08
SG11201501976SA (en) 2015-04-29
EP2708145A1 (en) 2014-03-19
PH12015500545A1 (en) 2015-05-04
US11116779B2 (en) 2021-09-14
CN104780781A (zh) 2015-07-15
EP2708145A8 (en) 2014-09-03
US20150238508A1 (en) 2015-08-27
US20190381077A1 (en) 2019-12-19
US20210401862A1 (en) 2021-12-30
MY182944A (en) 2021-02-05

Similar Documents

Publication Publication Date Title
BR112015005758A2 (pt) métodos para modular níveis de corticosterona em indivíduos psicologicamente estressados
AR118722A2 (es) Proteínas tóxicas para especies de insectos hemípteros
MY191035A (en) Affinity-oligonucleotide conjugates and uses thereof
BR112017023868A2 (pt) anticorpos anti-itga3, anticorpos anti-itga3 ativáveis, e métodos de uso dos mesmos
MX2016008086A (es) Mezclas que comprenden un polímero superabsorbente (sap) y un bioplaguicida.
SG10201803042PA (en) Anti-tim-3 antibodies
BR112014027165A2 (pt) antagonistas de st2l e métodos de uso
BR112015027322A2 (pt) compostos antissenso conjugados e sua utilização
UY4236Q (es) Configuración aplicada en zapato
UA109938C2 (uk) Механічна фіксуюча система для будівельних панелей
UY34218A (es) MÉTODO DE DETECCIÓN DEL EVENTO DE SOJA pDAB9582.814.19.1
MX2014003464A (es) Sistema de fracturación ajustable.
MX2014011134A (es) Compuestos de carbamato y preparacion y uso de los mismos.
UY34350A (es) Derivados de pirazolquinolinona, su preparación y su uso terapéutico.
EP3865135A3 (en) Neuroactive steroids for use in therapy
CA2902795C (en) Glycopyrrolate salts
EA201390254A1 (ru) Модифицированные полипептиды релаксина и их применение
MX2016004802A (es) Anticuerpos anti-r-espondina (anti-rspo) y metodos de uso.
MX2017013013A (es) Estireno funcionalizado con [bis(trihidrocarbilsilil)aminosililo] y un metodo para su preparacion.
NZ603171A (en) Gate for barrier system and methods for the assembly and use thereof
BR112014027239A2 (pt) peptídeo, método de identificação de peptídeos, método para o tratamento de câncer, nucleotídeo, vetor, uso de um peptídeo e invenção
WO2011097596A3 (en) Methods of using agents that modulate claudin expression
GB2497453A (en) Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV
TWM433118U (en) Vamp
WO2016176652A3 (en) Modified stem cells and uses thereof

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]